• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association of promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.

作者信息

Namba Natsumi, Kawasaki Aya, Sada Ken-Ei, Hirano Fumio, Kobayashi Shigeto, Yamada Hidehiro, Furukawa Hiroshi, Shimada Kota, Hashimoto Atsushi, Matsui Toshihiro, Nagasaka Kenji, Sugihara Takahiko, Suzuki Aika, Yamagata Kunihiro, Sumida Takayuki, Tohma Shigeto, Homma Sakae, Ozaki Shoichi, Hashimoto Hiroshi, Makino Hirofumi, Arimura Yoshihiro, Harigai Masayoshi, Tsuchiya Naoyuki

机构信息

Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

School of Medical Sciences, University of Tsukuba, Tsukuba, Japan.

出版信息

Ann Rheum Dis. 2019 Aug;78(8):1144-1146. doi: 10.1136/annrheumdis-2018-214263. Epub 2019 Feb 14.

DOI:10.1136/annrheumdis-2018-214263
PMID:30765393
Abstract
摘要

相似文献

1
Association of promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.启动子多态性与髓过氧化物酶-抗中性粒细胞胞浆抗体相关血管炎间质性肺病的关联
Ann Rheum Dis. 2019 Aug;78(8):1144-1146. doi: 10.1136/annrheumdis-2018-214263. Epub 2019 Feb 14.
2
A common MUC5B promoter polymorphism and pulmonary fibrosis.一种常见的MUC5B启动子多态性与肺纤维化。
N Engl J Med. 2011 Apr 21;364(16):1503-12. doi: 10.1056/NEJMoa1013660.
3
Influence of MUC5B gene on antisynthetase syndrome.MUC5B 基因对抗合成酶综合征的影响。
Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0.
4
MUC5B promoter polymorphism and pulmonary fibrosis.MUC5B启动子多态性与肺纤维化
N Engl J Med. 2011 Jul 14;365(2):178; author reply 178-9. doi: 10.1056/NEJMc1105707.
5
Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.自身免疫性肌炎患者 MUC5B 启动子变异与间质性肺病风险的探索。
Respir Med. 2017 Sep;130:52-54. doi: 10.1016/j.rmed.2017.07.010. Epub 2017 Jul 17.
6
Interaction between the promoter polymorphism and mucin expression: is there a difference according to ILD subtype?启动子多态性与黏蛋白表达的相互作用：根据间质性肺病亚型是否存在差异？
Thorax. 2020 Oct;75(10):901-903. doi: 10.1136/thoraxjnl-2020-214579. Epub 2020 Jun 24.
7
MUC5B promoter polymorphism and interstitial lung abnormalities.MUC5B 启动子多态性与肺间质异常。
N Engl J Med. 2013 Jun 6;368(23):2192-200. doi: 10.1056/NEJMoa1216076. Epub 2013 May 21.
8
Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the Promoter Variant.类风湿关节炎队列中亚临床间质性肺疾病的前瞻性识别与启动子变异有关。
Am J Respir Crit Care Med. 2022 Feb 15;205(4):473-476. doi: 10.1164/rccm.202109-2087LE.
9
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.吸烟者客观识别的间质性改变的临床和遗传关联
Chest. 2017 Oct;152(4):780-791. doi: 10.1016/j.chest.2017.04.185. Epub 2017 May 12.
10
Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.粘蛋白5B启动子多态性与中国男性间质性肺疾病易感性相关。
PLoS One. 2014 Aug 14;9(8):e104919. doi: 10.1371/journal.pone.0104919. eCollection 2014.

引用本文的文献

1
Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions.抗中性粒细胞胞浆抗体相关血管炎患者间质性肺疾病治疗的临床见解与治疗策略：当前趋势与未来方向
J Clin Med. 2025 Jun 30;14(13):4631. doi: 10.3390/jcm14134631.
2
Clinical features, radiological findings and prognosis of microscopic polyangiitis with interstitial lung disease: a retrospective matched control study.显微镜下多血管炎合并间质性肺疾病的临床特征、影像学表现及预后：一项回顾性配对对照研究
BMC Pulm Med. 2024 Dec 9;24(1):605. doi: 10.1186/s12890-024-03423-w.
3
Immune-mediated lung diseases: A narrative review.
免疫介导的肺部疾病：一篇叙述性综述。
Front Med (Lausanne). 2023 Apr 6;10:1160755. doi: 10.3389/fmed.2023.1160755. eCollection 2023.
4
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.抗中性粒细胞胞质抗体相关性血管炎的遗传学：在发病机制、分类和管理中的作用。
Nat Rev Rheumatol. 2022 Oct;18(10):559-574. doi: 10.1038/s41584-022-00819-y. Epub 2022 Sep 15.
5
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report.互联互通之声；欧洲血管炎学会2022年报告
Kidney Int Rep. 2022 May 25;7(8):1745-1757. doi: 10.1016/j.ekir.2022.05.018. eCollection 2022 Aug.
6
Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.MPO-ANCA阳性间质性肺疾病的抗炎和/或抗纤维化治疗：简短综述
J Clin Med. 2022 Jul 1;11(13):3835. doi: 10.3390/jcm11133835.
7
MPO-ANCA positive interstitial pneumonia: Current knowledge and future perspectives.髓过氧化物酶抗中性粒细胞胞浆抗体阳性间质性肺炎：当前认知与未来展望
Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021045. doi: 10.36141/svdld.v38i4.11808. Epub 2022 Jan 13.
8
Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.肺部疾病模式可预测MPO-ANCA相关性血管炎患者的生存情况：一项单中心回顾性研究
Clin Rheumatol. 2022 Mar;41(3):783-793. doi: 10.1007/s10067-021-05964-5. Epub 2021 Nov 27.
9
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review.抗中性粒细胞胞浆抗体相关性间质性肺疾病：综述。
Eur Respir Rev. 2021 Nov 8;30(162). doi: 10.1183/16000617.0123-2021. Print 2021 Dec 31.
10
Interstitial Lung Disease and Diffuse Alveolar Hemorrhage, the Two Key Pulmonary Manifestations in Microscopic Polyangiitis.间质性肺病与弥漫性肺泡出血，显微镜下多血管炎的两种关键肺部表现。
Tuberc Respir Dis (Seoul). 2021 Oct;84(4):255-262. doi: 10.4046/trd.2021.0065. Epub 2021 Aug 20.